CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors
2024 · Nature · 123 citations
https://doi.org/10.1038/s41586-024-07943-7
H
Haniel A. Araújo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
165
Papers
1.1K
Citations
9
h-index
9
i10-index
Haniel A. Araújo is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations & Genetic factors in colorectal cancer. The author has an h-index of 9, co-authored 141 publications.
ORCID: 0000-0002-7980-0515Papers by this author
worksSupplementary Table S4 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025373
Supplementary Table S5 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025370.v1
Supplementary Table S5 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025370
Supplementary Figure S10 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025409
Supplementary Figure S1 from Co-mutations and KRAS G12C inhibitor efficacy in advanced NSCLC
2024 · 0 citations
https://doi.org/10.1158/2159-8290.27025412
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat